Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioShield Should Extend Liability Protection To Unapproved Products – BIO

Executive Summary

Liability protections under "Project BioShield" should be extended to companies that make unapproved bioterrorism countermeasures available in an emergency situation, the Biotechnology Industry Organization said
Advertisement

Related Content

“BioShield” Law Nears Passage; FDA Proposes “Pre-Pre-IND” Meetings
“BioShield” Law Nears Passage; FDA Proposes “Pre-Pre-IND” Meetings
BioShield House Compromise Could Serve As Template For Senate
BioShield House Compromise Could Serve As Template For Senate
PhRMA Urges Antitrust Exemption For Bioterrorism Research
BioShield Funding: Aventis Prefers Production Deals, Not R&D Support
BioShield Bill Creates “Emergency Use Authority” Tied To Monetary Penalties
“Project BioShield”: Industry Has Concerns, FDA Offers Support
Vaccine Definition Refined In Homeland Security Bill To Include Thimerosal
Vaccine Definition Refined In Homeland Security Bill To Include Thimerosal
Advertisement
UsernamePublicRestriction

Register

PS041510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel